ATE332307T1 - Wachstumhormonsekretionsförderer - Google Patents

Wachstumhormonsekretionsförderer

Info

Publication number
ATE332307T1
ATE332307T1 AT03714333T AT03714333T ATE332307T1 AT E332307 T1 ATE332307 T1 AT E332307T1 AT 03714333 T AT03714333 T AT 03714333T AT 03714333 T AT03714333 T AT 03714333T AT E332307 T1 ATE332307 T1 AT E332307T1
Authority
AT
Austria
Prior art keywords
growth hormone
hormone secretion
compounds
secretion promoters
novel
Prior art date
Application number
AT03714333T
Other languages
English (en)
Inventor
Britta Evers
Gerd Ruehter
De La Nava Eva Maria Martin
Mark Joseph Tebbe
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0208120A external-priority patent/GB0208120D0/en
Priority claimed from GB0208116A external-priority patent/GB0208116D0/en
Priority claimed from GB0208119A external-priority patent/GB0208119D0/en
Priority claimed from GB0208117A external-priority patent/GB0208117D0/en
Priority claimed from GB0208118A external-priority patent/GB0208118D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE332307T1 publication Critical patent/ATE332307T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Golf Clubs (AREA)
  • Conductive Materials (AREA)
  • Illuminated Signs And Luminous Advertising (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
AT03714333T 2002-04-09 2003-03-31 Wachstumhormonsekretionsförderer ATE332307T1 (de)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US37127102P 2002-04-09 2002-04-09
US37127002P 2002-04-09 2002-04-09
US37127802P 2002-04-09 2002-04-09
US37127502P 2002-04-09 2002-04-09
US37127702P 2002-04-09 2002-04-09
GB0208120A GB0208120D0 (en) 2002-04-09 2002-04-09 Growth hormone secretagogues
GB0208116A GB0208116D0 (en) 2002-04-09 2002-04-09 Growth hormone secretagogues
GB0208119A GB0208119D0 (en) 2002-04-09 2002-04-09 Growth Hormone Secretagogues
GB0208117A GB0208117D0 (en) 2002-04-09 2002-04-09 Growth hormone secretagogues
GB0208118A GB0208118D0 (en) 2002-04-09 2002-04-09 Growth hormone secretagogues

Publications (1)

Publication Number Publication Date
ATE332307T1 true ATE332307T1 (de) 2006-07-15

Family

ID=29255779

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03714333T ATE332307T1 (de) 2002-04-09 2003-03-31 Wachstumhormonsekretionsförderer
AT03716747T ATE338767T1 (de) 2002-04-09 2003-03-31 Dipeptidische wachstumshormonsekretionsförderern

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT03716747T ATE338767T1 (de) 2002-04-09 2003-03-31 Dipeptidische wachstumshormonsekretionsförderern

Country Status (7)

Country Link
US (1) US7396846B2 (de)
EP (2) EP1497316B1 (de)
AT (2) ATE332307T1 (de)
AU (2) AU2003218337A1 (de)
DE (2) DE60308166T2 (de)
ES (2) ES2271557T3 (de)
WO (2) WO2003087069A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ546504A (en) * 2003-10-24 2009-01-31 Aventis Pharma Inc Novel keto-oxadiazole derivatives as cathepsin inhibitors
EP1781311A4 (de) 2004-08-18 2010-02-17 Elixir Pharmaceuticals Inc Wachstumshormonsekretagoge
EP1824484A1 (de) * 2004-11-18 2007-08-29 Pfizer Products Incorporated Arzneimittel und prodrugs zur behandlung des energiegleichgewichts von wiederkäuern
MX2009002492A (es) 2006-09-08 2009-08-28 Bayer Schering Pharma Ag Agentes que comprenden compuestos marcados con 18f y metodos relacionados.
JP5268264B2 (ja) * 2007-02-07 2013-08-21 住友精化株式会社 アルカンジスルホニルハライドの製造方法
EP2471363A1 (de) * 2010-12-30 2012-07-04 Bayer CropScience AG Verwendung von Aryl-, Heteroaryl- und Benzylsulfonamidocarbonsäuren, -carbonsäureestern, -carbonsäureamiden und -carbonitrilen oder deren Salze zur Steigerung der Stresstoleranz in Pflanzen

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711495A (en) 1970-01-07 1973-01-16 Merck & Co Inc Isoxazalin-3-yl-substituted-5-nitroimidazoles
DE2359922A1 (de) 1973-12-01 1975-06-05 Hoechst Ag (1-alkyl-5-nitro-imidazolyl-2-alkyl)- heteroaryl-verbindungen und verfahren zu ihrer herstellung
US5242903A (en) 1989-08-05 1993-09-07 Bayer Aktiengesellschaft Renin inhibitors
US5206235A (en) 1991-03-20 1993-04-27 Merck & Co., Inc. Benzo-fused lactams that promote the release of growth hormone
US5663146A (en) 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
US5401851A (en) 1992-06-03 1995-03-28 Eli Lilly And Company Angiotensin II antagonists
US5583130A (en) 1992-09-25 1996-12-10 Merck & Co., Inc. Benzo-fused lactams promote release of growth hormone
US5536716A (en) 1992-12-11 1996-07-16 Merck & Co., Inc. Spiro piperidines and homologs which promote release of growth hormone
NZ258412A (en) 1992-12-11 1997-01-29 Merck & Co Inc Spiro-fused piperidine derivatives and pharmaceutical compositions
IL107836A (en) 1992-12-11 1998-01-04 Merck & Co Inc Spiro piperidines and homologues, their preparation and pharmaceutical preparations containing them
DE4302957A1 (de) 1993-02-03 1994-08-04 Bayer Ag Imidazolyl-substituierte Phenylessigsäureprolinamide
US5344937A (en) 1993-04-20 1994-09-06 Eli Lilly And Company Alkyl substituted nitroimidazole acetic acids
FI961681L (fi) 1993-10-19 1996-06-12 Merck & Co Inc Bisfosfonaattien ja kasvuhormoonin eritystä lisäävien aineiden yhdistelmä
US5492920A (en) 1993-12-10 1996-02-20 Merck & Co., Inc. Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
US5494919A (en) 1993-11-09 1996-02-27 Merck & Co., Inc. 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
US5492916A (en) 1993-12-23 1996-02-20 Merck & Co., Inc. Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
AU684878B2 (en) 1993-11-24 1998-01-08 Merck & Co., Inc. Compounds and the use thereof to promote the release of growth hormone(s)
US5721250A (en) 1993-12-23 1998-02-24 Merck & Co. Inc. Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone
ZA9410186B (en) 1994-01-10 1995-08-25 Santiago Abelardo Bojali Jaber Savourless antiamoebic antiprotozoan chemical product and procedure to obtain it
EE9600186A (et) 1994-05-07 1997-08-15 Boehringer Ingelheim Kg Neurokiniini (tahhüülkiniini) antagonistid
US5661161A (en) 1994-09-29 1997-08-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US5798337A (en) 1994-11-16 1998-08-25 Genentech, Inc. Low molecular weight peptidomimetic growth hormone secretagogues
US5559128A (en) 1995-04-18 1996-09-24 Merck & Co., Inc. 3-substituted piperidines promote release of growth hormone
WO1996035713A1 (en) 1995-05-08 1996-11-14 Pfizer, Inc. Dipeptides which promote release of growth hormone
DE69533991T2 (de) 1995-05-29 2006-04-13 Pfizer Inc. Dipeptide, die die ausschüttung von wachstumshormonen stimulieren
US5756528A (en) 1995-06-06 1998-05-26 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP0761220A1 (de) 1995-08-21 1997-03-12 Eli Lilly And Company 2-Acylaminopropanamide zur Förderung der Wachstumshormon-Sekretion
AU6724496A (en) 1995-08-21 1997-03-12 Eli Lilly And Company 2-acylaminopropanamines as growth hormone secretagogues
AU7468596A (en) 1995-10-27 1997-05-15 Merck & Co., Inc. Process for the preparation of a growth hormone secretagogue
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
WO1997034604A1 (en) 1996-03-21 1997-09-25 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
WO1997041878A1 (en) 1996-05-07 1997-11-13 Merck & Co., Inc. Treatment of mood disorders with a growth hormone secretagogue
US5830855A (en) 1996-09-12 1998-11-03 Utah State University Lipodepsipeptides as antifungal and fungicidal agents
WO1998016527A1 (en) 1996-10-15 1998-04-23 Fujisawa Pharmaceutical Co., Ltd. Benzoxepine derivatives which promote release of growth hormone
WO1998018815A1 (en) 1996-10-25 1998-05-07 Merck & Co., Inc. Convergent process for the preparation of a growth hormone secretagogue
US6046333A (en) 1996-10-25 2000-04-04 Merck & Co., Inc. Convergent process for the preparation of a growth hormone secretagogue
UA53716C2 (uk) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)
ZA987385B (en) 1997-08-19 2000-04-18 Lilly Co Eli Growth hormone secretagogues.
US6329342B1 (en) 1997-08-19 2001-12-11 Eli Lilly And Company Treatment of congestive heart failure with growth hormone secretagogues
ZA987383B (en) 1997-08-19 2000-02-17 Lilly Co Eli Treatment of congestive heart failure with growth hormone secretagogues.
US6639076B1 (en) 1998-08-18 2003-10-28 Eli Lilly And Company Growth hormone secretagogues
CA2341649A1 (en) 1998-09-02 2000-03-09 Merck & Co., Inc. Enhancement of return to independent living status with a growth hormone secretagogue
CO5160260A1 (es) * 1999-02-19 2002-05-30 Lilly Co Eli Secretagogos de la hormona del crecimiento derivados de imi- dazol 1,4- substituido
BR0114630A (pt) * 2000-10-13 2003-07-01 Lilly Co Eli Secretagogos de hormÈnio do crescimento
CA2628025C (en) 2005-11-22 2011-10-25 Lg Electronics Inc. Device for limiting current of electric appliance

Also Published As

Publication number Publication date
ES2266798T3 (es) 2007-03-01
US7396846B2 (en) 2008-07-08
DE60308166D1 (de) 2006-10-19
EP1497317B1 (de) 2006-09-06
ES2271557T3 (es) 2007-04-16
AU2003220441A1 (en) 2003-10-27
AU2003220441A8 (en) 2003-10-27
ATE338767T1 (de) 2006-09-15
WO2003087069A3 (en) 2004-03-25
AU2003218337A1 (en) 2003-10-27
WO2003087070A2 (en) 2003-10-23
WO2003087069A2 (en) 2003-10-23
AU2003218337A8 (en) 2003-10-27
EP1497316A2 (de) 2005-01-19
WO2003087070A3 (en) 2003-12-31
DE60306636T2 (de) 2007-07-05
EP1497316B1 (de) 2006-07-05
US20050240001A1 (en) 2005-10-27
DE60308166T2 (de) 2007-07-19
EP1497317A2 (de) 2005-01-19
DE60306636D1 (de) 2006-08-17

Similar Documents

Publication Publication Date Title
NO20031687L (no) Veksthormonsekretagoger
MY138258A (en) Growth hormone secretagogues
BR0307432A (pt) Difluormetiltiazolilcarboxanilidas
CY1108156T1 (el) Στερεοεκλεκτικη συνθεση αναλογων βιταμινης d
ATE332307T1 (de) Wachstumhormonsekretionsförderer
TW200633977A (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
DK1441724T3 (da) Fremgangsmåde til forögelse af endogene testosteronniveauer
ATE372330T1 (de) N-sulfonylurea-apoptosis-förderer
MXPA05011289A (es) Compuestos de fosfato que tienen actividad inmunomoduladora.
DE602005014632D1 (de) Pyrrol- bzw. imidazolamide zur behandlung von obesitas
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
DE50303586D1 (de) Methylthiophencarboxanilide
ATE428692T1 (de) 24-schwefel-substituierte 1-alpha-25-dihydroxy- vitamin-d3-analogen
TW200720225A (en) New one-step synthesis of useful disubstituted amines
DE602004018324D1 (de) Steroid modifizierte solatriosen
DE50312447D1 (de) Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin
DK1572615T3 (da) Fremgangsmåde til syntese af peptider indeholdende en 4-hydroxyprolin-substruktur
ATE529115T1 (de) Kombinierte verwendung einer prostaglandin- verbindung und eines protonenpumpenhemmers zur behandlung von magen-darm-erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties